Circulating tumour DNA dynamics predict recurrence in stage III melanoma patients receiving neoadjuvant immunotherapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Circulating tumour DNA dynamics predict recurrence in stage III melanoma patients receiving neoadjuvant immunotherapy ; volume:43 ; number:1 ; day:21 ; month:8 ; year:2024 ; pages:1-9 ; date:12.2024
Journal of experimental & clinical cancer research ; 43, Heft 1 (21.8.2024), 1-9, 12.2024
- Urheber
-
Chan, Wei Yen
Lee, Jenny H.
Stewart, Ashleigh
Diefenbach, Russell J.
Gonzalez, Maria
Menzies, Alexander M.
Blank, Christian
Scolyer, Richard A.
Long, Georgina V.
Rizos, Helen
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13046-024-03153-1
- URN
-
urn:nbn:de:101:1-2411072101579.292948396317
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Chan, Wei Yen
- Lee, Jenny H.
- Stewart, Ashleigh
- Diefenbach, Russell J.
- Gonzalez, Maria
- Menzies, Alexander M.
- Blank, Christian
- Scolyer, Richard A.
- Long, Georgina V.
- Rizos, Helen
- SpringerLink (Online service)
Ähnliche Objekte (12)
Radiotherapy for patients with locally advanced esophageal squamous cell carcinoma receiving neoadjuvant immunotherapy combined with chemotherapy
Imaging of tumour response to immunotherapy
Pseudoprogression with Neoadjuvant Immunotherapy for Cutaneous Melanoma
Regional lymph node changes on breast MRI in patients with early-stage breast cancer receiving neoadjuvant chemo-immunotherapy
HNSCC: tumour antigens and their targeting by immunotherapy
Postoperative recurrence in locally advanced rectal cancer: how does neoadjuvant treatment affect recurrence pattern?
Neoadjuvant immunotherapy across cancers: meeting report from the Immunotherapy Bridge—December 1st–2nd, 2021
The tumour microenvironment, treatment resistance and recurrence in glioblastoma
Infectious morbidity in pediatric patients receiving neoadjuvant chemotherapy for sarcoma
Inhibition of post-surgery tumour recurrence via a sprayable chemo-immunotherapy gel releasing PD-L1 antibody and platelet-derived small EVs
Does immunotherapy reduce the recurrence rate in nasal polyposis?
Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC
Radiotherapy for patients with locally advanced esophageal squamous cell carcinoma receiving neoadjuvant immunotherapy combined with chemotherapy
Imaging of tumour response to immunotherapy
Pseudoprogression with Neoadjuvant Immunotherapy for Cutaneous Melanoma
Regional lymph node changes on breast MRI in patients with early-stage breast cancer receiving neoadjuvant chemo-immunotherapy
HNSCC: tumour antigens and their targeting by immunotherapy
Postoperative recurrence in locally advanced rectal cancer: how does neoadjuvant treatment affect recurrence pattern?
Neoadjuvant immunotherapy across cancers: meeting report from the Immunotherapy Bridge—December 1st–2nd, 2021
The tumour microenvironment, treatment resistance and recurrence in glioblastoma
Infectious morbidity in pediatric patients receiving neoadjuvant chemotherapy for sarcoma
Inhibition of post-surgery tumour recurrence via a sprayable chemo-immunotherapy gel releasing PD-L1 antibody and platelet-derived small EVs
Does immunotherapy reduce the recurrence rate in nasal polyposis?
Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC
Radiotherapy for patients with locally advanced esophageal squamous cell carcinoma receiving neoadjuvant immunotherapy combined with chemotherapy
Imaging of tumour response to immunotherapy
Pseudoprogression with Neoadjuvant Immunotherapy for Cutaneous Melanoma
Regional lymph node changes on breast MRI in patients with early-stage breast cancer receiving neoadjuvant chemo-immunotherapy
HNSCC: tumour antigens and their targeting by immunotherapy
Postoperative recurrence in locally advanced rectal cancer: how does neoadjuvant treatment affect recurrence pattern?
Neoadjuvant immunotherapy across cancers: meeting report from the Immunotherapy Bridge—December 1st–2nd, 2021
The tumour microenvironment, treatment resistance and recurrence in glioblastoma
Infectious morbidity in pediatric patients receiving neoadjuvant chemotherapy for sarcoma
Inhibition of post-surgery tumour recurrence via a sprayable chemo-immunotherapy gel releasing PD-L1 antibody and platelet-derived small EVs
Does immunotherapy reduce the recurrence rate in nasal polyposis?